Fig 1: In vitro binding experiments with purified SARS-CoV-2 spike protein confirm human CD209 as a functional binding target.(A) Human cell lines overexpressing cell-surface CD209 protein gain the ability to specifically bind SARS-CoV-2 spike. The density plots represent flow cytometry measurements of HEK293 cells stained with fluorescently conjugated tetramers of SARS-CoV-2 spike protein or a tag-only protein control. Blue distributions are cells with surface CD209, while red are control-transfected cells. Light shades indicate a negative control tetramer that was used for staining, while dark shades are stained with spike protein. (B) Purified recombinant CD209 ectodomains interact with the spike protein of SARS-CoV-2 in an in vitro binding assay. A dilution series of purified spike protein was applied over immobilised CD209, ACE2 (positive control), or a negative control protein. A plot of quantified absorbance is displayed alongside a representative assay plate. Error bars are standard deviations of two replicates.
Supplier Page from OriGene Technologies for DC SIGN (CD209) (NM_021155) Human Untagged Clone